Page URL: https://www.bionews.org.uk/page_94319

Global study finds 48 new multiple sclerosis risk genes

7 October 2013
Appeared in BioNews 725

A group of international researchers has identified 48 new genetic variants that influence the risk of developing multiple sclerosis (MS). This brings the number of genetic 'risk factors' linked to the disease to 110.

The study, published in the journal Nature Genetics, examined DNA samples from around 80,000 people with and without MS. It is thought to be the largest investigation of multiple sclerosis genetics yet performed and involved 193 scientists from 84 research groups in 13 different countries.

One of the leading scientists on the project, Dr David Booth from the University of Sydney, commented: 'Every one of those new genes is potentially providing us with a new way to understand the disease and to come up with new therapies for the disease'.

In MS, the coating around nerve fibres, called myelin, is damaged as the immune system mistakes myelin for a foreign body and attacks it. Depending on where in the central nervous system the damage occurs, this can cause problems with mobility, balance, sensation and cognition. MS is normally diagnosed in people between the ages of 20 and 40 and is a lifelong, degenerative illness. Around 2.5 million people worldwide are thought to be affected. Treatments exist, but a cure remains elusive.

The genes implicated in this study underline the central role the immune system plays in the disease and show some overlap with other autoimmune diseases, like inflammatory bowel disease and coeliac disease.

Dr Booth said that the researchers would now look at 'which processes are tagged by groups of genes and that will give us specific information on immune processes that are not functioning as they should'.

Dr Susan Kohlhaas, head of biomedical research at the MS Society in the UK, which co-funded the study, said: 'We need to discover as much as we can about the factors that may increase a person's risk of developing MS if we're to find new ways of treating or even, one day, preventing the condition. Genes are one of the key risk factors, so we're delighted to have co-funded this work, which has identified several new avenues for MS research to follow'.

SOURCES & REFERENCES
Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis
Nature Genetics |  29 September 2013
Multiple sclerosis researchers celebrate breakthrough gene discovery
The Guardian |  30 September 2013
Multiple sclerosis: Researchers publish 48 genes linked to the disease
The Independent |  30 September 2013
Researchers uncover 48 new genetic variants associated with multiple sclerosis
Eurekalert (press release) |  29 September 2013
RELATED ARTICLES FROM THE BIONEWS ARCHIVE
27 February 2017 - by Jamie Rickman 
A study has demonstrated that a new, one-off stem cell treatment for multiple sclerosis can 'freeze' progression of the disease for five years in some patients...
6 June 2016 - by Dr Lucy Freem 
A gene variant has been linked to early onset multiple sclerosis in a small number of cases, lending weight to the hypothesis that genetic factors underlie multiple sclerosis more widely...
26 January 2015 - by Dr Tamara Hirsch 
An early clinical trial investigating a new form of stem cell therapy for multiple sclerosis has demonstrated neurological improvement and enhanced quality of life for patients...
9 June 2014 - by Isobel Steer 
Human embryonic stem cells have been shown to be more effective in treating multiple sclerosis (MS) in mice than bone marrow stem cells, a study has found...
19 May 2014 - by Alice Plein 
Mice with a viral form of multiple sclerosis are able to walk again after receiving a transplant of human stem cells, scientists report...
23 July 2012 - by Holly Rogers 
A genetic variation could explain why a previously promising class of drugs do not work as multiple sclerosis treatments despite being used successfully in other autoimmune diseases...
28 May 2012 - by Dr Lux Fatimathas 
A chemical produced by stem cells promotes recovery in mice with the autoimmune neurological disease, multiple sclerosis. Hepatocyte growth factor, which is produced by human mesenchymal stem cells, appeared to both repair existing damage and prevent future neurological harm in a mouse model of the disease...
12 December 2011 - by Owen Clark 
A rare genetic variant causing lower levels of vitamin D has been linked to multiple sclerosis (MS), according to scientists...
15 August 2011 - by Dr Rebecca Hill 
Researchers have identified 29 new genetic variants with a link to multiple sclerosis (MS). This brings the total number of genetic changes associated with the disease, which affects around 2.5 million people worldwide, to nearly 50...
HAVE YOUR SAY
Log in to add a Comment.

By posting a comment you agree to abide by the BioNews terms and conditions


Syndicate this story - click here to enquire about using this story.